YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells
Authors:
Open Access
- 18 September 2020
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 13 (1) , 1-9
Abstract
RNA methylation can reverse the methylation modification at the RNA level, which is an extremely important epigenetic modification. The function and mechanism of YTHDF2, as a reader of m6A modification, in epithelial ovarian cancer (EOC) have not been elucidated so far. This study aimed to investigate how YTHDF2 and miR-145 modulated EOC progression through m6A modification. It demonstrated that YTHDF2 was significantly upregulated in EOC tissues compared with normal ovarian tissues. Further functional studies confirmed that YTHDF2 significantly promoted the proliferation and migration of EOC cell lines and reduced the global 6-methyladenine (m6A) mRNA levels. Next, the expression levels of miR-145 and YTHDF2 were found to be inversely correlated in ovarian cancer tissues and cells, and YTHDF2 was the direct target gene of miR-145. A crucial crosstalk occurred between miR-145 and YTHDF2 via a double-negative feedback loop. The overexpression of YTHDF2 rescued miR-145-induced reduction of the proliferation and migration of EOC cells. Hence, YTHDF2 and miR-145, as two crucial m6A regulators, were involved in the progression of EOC by indirectly modulating m6A levels. The findings of this study on YTHDF2 and miR-145 might provide new insights into carcinogenesis and new potential therapeutic targets for EOC.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81702577)
- Natural Science Basic Research Program of Shaanxi (2018JQ8035)
- the Fundamental Research Funds for the Central Universities (XZY012019105)
This publication has 28 references indexed in Scilit:
- 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancerOncotarget, 2017
- m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation ProgramCancer Cell, 2017
- MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 ProteinJournal of Biological Chemistry, 2017
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processingHepatology, 2016
- YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complexNature Communications, 2016
- HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing EventsCell, 2015
- N6-methyladenosine marks primary microRNAs for processingNature, 2015
- MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian CancerTechnology in Cancer Research & Treatment, 2014
- N6-methyladenosine-dependent regulation of messenger RNA stabilityNature, 2013
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011